Spots Global Cancer Trial Database for pancreatic cancer
Every month we try and update this database with for pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | NCT00667641 | Breast Cancer Colorectal Canc... Head and Neck C... Lung Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Prostate Cancer Unspecified Adu... | bortezomib paclitaxel | 18 Years - | Rutgers, The State University of New Jersey | |
| AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | NCT03205176 | Malignant Solid... Lymphoma Ovarian Cancer Breast Cancer Pancreatic Canc... Prostate Cancer | AZD5153 Olaparib | 18 Years - 130 Years | AstraZeneca | |
| Trial Comparing EUS-guided Radiofrequency Ablation vs. EUS-guided Celiac Plexus Neurolysis | NCT03152487 | Pancreatic Carc... Pancreatic Aden... Pancreatic Neop... Pancreatic Canc... Pancreatic Canc... | Celiac Plexus N... Radiofrequency ... | 19 Years - | AdventHealth | |
| Transcatheter Arterial Infusion to Patients With Advanced Pancreatic Cancer | NCT06196788 | Pancreatic Canc... | Gemcitabine Nab paclitaxel | 18 Years - 80 Years | Fudan University | |
| Frequency of Methods of Local Invasion of Pancreatic Adenocarcinoma | NCT01129167 | Pancreatic Canc... | 18 Years - 85 Years | Columbia University | ||
| Metastatic Advanced Pancreas Sorafenib | NCT00758381 | Locally Advance... | Sorafenib 400 m... Gemcitabina, Ci... | 18 Years - 75 Years | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente | |
| OH2 Oncolytic Viral Therapy in Pancreatic Cancer | NCT04637698 | Pancreatic Canc... | OH2 injection | 18 Years - 75 Years | Binhui Biopharmaceutical Co., Ltd. | |
| Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pancreas | NCT02451982 | Pancreatic Canc... | Cyclophosphamid... GVAX pancreatic... Nivolumab Urelumab BMS-986253 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | NCT03104439 | Microsatellite ... Pancreatic Canc... MSI High Colore... | Nivolumab Ipilimumab Radiation Thera... | 18 Years - | Massachusetts General Hospital | |
| The HistoSonics Edison™ System for Treatment of Pancreatic Adenocarcinoma Using Histotripsy | NCT06282809 | Pancreas Cancer Adenocarcinoma ... Pancreatic Canc... Tumor of Pancre... | HistoSonics Edi... | 18 Years - | HistoSonics, Inc. | |
| Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | NCT00002689 | Pancreatic Canc... | dexamethasone fluorouracil brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation | NCT02042378 | Pancreatic Canc... Pancreatic Duct... | Rucaparib | 18 Years - | pharmaand GmbH | |
| Interleukin-12 in Treating Patients With Cancer in the Abdomen | NCT00003046 | Anal Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... | Recombinant Int... | 18 Years - | M.D. Anderson Cancer Center | |
| Integrated Care Pathway in Oncology (PASSION) | NCT04235556 | Colon Cancer Gastric Cancer Pancreatic Canc... Thoracic Neopla... Breast Cancer Ovarian Cancer Bladder Cancer Prostate Cancer | Care pathway un... | 18 Years - 80 Years | Assistance Publique - Hôpitaux de Paris | |
| Effects of Erector Spina Plan Block and Epidural Analgesia in Whipple Surgery | NCT06254430 | Pancreatic Canc... | 18 Years - 80 Years | Ankara City Hospital Bilkent | ||
| Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer | NCT03069664 | Pancreatic Canc... Pancreatic Duct... | ERCP Covered Self-ex... | 18 Years - | Helsinki University Central Hospital | |
| A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors | NCT05571839 | Cutaneous Melan... Non-small Cell ... Colorectal Neop... Pancreatic Neop... Mesothelioma | SGN-BB228 | 18 Years - | Seagen Inc. | |
| Pancreatic Cancer Genetic Epidemiology (PACGENE) Study | NCT00526578 | Pancreatic Canc... | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) | NCT03460769 | Pancreatic Canc... Chronic Pancrea... Diabetes Mellit... | Data Management... | 30 Years - 84 Years | M.D. Anderson Cancer Center | |
| A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer | NCT02048384 | Metastatic Panc... | metformin alone... metformin (Arm ... rapamycin (Arm ... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy in Treating Patients With Stage III or Stage IV Pancreatic Cancer That Cannot Be Removed by Surgery | NCT00004003 | Pancreatic Canc... | cisplatin fluorouracil gemcitabine hyd... | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours | NCT02423239 | Hepatocellular ... Pancreatic Canc... | Dexanabinol Sorafenib Nab-paclitaxel Gemcitabine | 18 Years - | e-Therapeutics PLC | |
| A Study of Gemcitabine and Demcizumab (OMP-21M18) With or Without Abraxane® as 1st-line Treatment in Subjects With Locally Advanced or Metastatic Pancreatic Cancer | NCT01189929 | Pancreatic Canc... | Demcizumab Abraxane® Gemcitabine | 21 Years - | Mereo BioPharma | |
| HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer | NCT06217042 | Pancreatic Canc... | HR070803; Oxali... gemcitabine; ca... | 18 Years - 75 Years | Fudan University | |
| Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005) | NCT03797326 | Advanced Solid ... Triple Negative... Ovarian Cancer Gastric Cancer Colorectal Canc... Glioblastoma Biliary Tract C... Pancreatic Canc... | Pembrolizumab Lenvatinib | 18 Years - | Merck Sharp & Dohme LLC | |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | NCT00547612 | Pancreatic Canc... | high performanc... pharmacological... [18F]-labeled s... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer | NCT06203821 | Pancreatic Canc... | NP137 | 18 Years - | University of Rochester | |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer | NCT00903396 | Anal Cancer Carcinoma of th... Colorectal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Gastrointestina... Liver Cancer Nausea and Vomi... Pancreatic Canc... Primary Periton... Small Intestine... | palonosetron hy... placebo | 18 Years - | Alliance for Clinical Trials in Oncology | |
| MR Guidance for Liver and Pancreas | NCT03582189 | Magnetic Resona... | MRI | 18 Years - | University Health Network, Toronto | |
| Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | NCT04068896 | Pancreatic Canc... Metastatic Cast... Bladder Cancer Melanoma Non-small Cell ... Colorectal Canc... Gastric Cancer Esophageal Canc... Ovarian Cancer Head Neck Squam... Prostate Cancer | NGM120 NGM120 NGM120 NGM120 NGM120 NGM120 Placebo | 18 Years - | NGM Biopharmaceuticals, Inc | |
| A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients | NCT02854072 | Pancreatic Canc... | GV1001 Gemcitabine Capecitabine | 19 Years - | Samsung Pharmaceutical Co., Ltd. | |
| Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer | NCT01218880 | Pancreatic Canc... | M2ES 7.5mg M2ES 15mg M2ES 30mg M2ES 45mg | 18 Years - 60 Years | Protgen Ltd | |
| A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma | NCT01472198 | Pancreatic Canc... | Simtuzumab Gemcitabine Placebo to matc... | 18 Years - | Gilead Sciences | |
| Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | NCT03435770 | Pancreatic Canc... Pancreatic Neop... Pancreatic Aden... Pancreatic Neur... Pancreatic Duct... | EUSRA RFA needl... | 21 Years - 99 Years | Singapore General Hospital | |
| Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer | NCT06217042 | Pancreatic Canc... | HR070803; Oxali... gemcitabine; ca... | 18 Years - 75 Years | Fudan University | |
| A Study of the Safety and Tolerance of CAN04 in Combination With FOLFIRINOX in Subjects With Metastatic Pancreatic Ductal Adenocarcinoma | NCT04990037 | Metastatic Panc... | CAN04 FOLFIRINOX | 18 Years - | Cantargia AB | |
| One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy | NCT00358397 | Tumors | Clostridium nov... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vitamin E δ-Tocotrienol Multiple Dose in Healthy Subjects | NCT01450046 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers | NCT00626158 | Pancreatic Canc... Biliary Cancer | gemcitabine capecitabine | 18 Years - | University of California, San Francisco | |
| Improving REsectability in Pancreatic NEoplasms (IRENE) | NCT03460925 | Pancreatic Canc... Stereotactic Bo... | SBRT plus chemo... | 18 Years - | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| BMS-247550 in Treating Patients With Advanced Pancreatic Cancer | NCT00016965 | Pancreatic Canc... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer | NCT05394259 | Pancreatic Canc... Breast Cancer Hepatocellular ... | Piflufolastat F... | 18 Years - | M.D. Anderson Cancer Center | |
| SBRT Plus vNKT for Pancreatic Cancer | NCT05783076 | Pancreatic Canc... | Stereotactic bo... adoptive cell t... | 18 Years - | Changhai Hospital | |
| Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX therapY | NCT04789980 | Locally Advance... Metastatic Panc... | 19 Years - | Boryung Pharmaceutical Co., Ltd | ||
| Preoperative Prehabilitation for Sarcopenic Patients Prior to Pancreatic Surgery for Cancer | NCT04469504 | Sarcopenia Pancreatic Canc... | Prehabilitation... Oral Impact | 18 Years - | University Hospital, Lille | |
| Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | NCT00053222 | Pancreatic Canc... | arsenic trioxid... | 18 Years - | University of Chicago | |
| Influence of Local Anesthetic Administration on the Cancer Recurrence Rate After Pancreatic Oncologic Surgery | NCT04449289 | Pancreatic Canc... | Intravenous lid... Epidural ropiva... | 18 Years - 80 Years | Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor | |
| Clinical Study of LY011 in the Treatment of Advanced Pancreatic Cancer | NCT04966143 | Pancreatic Canc... | LY011 | 18 Years - 70 Years | Shanghai Longyao Biotechnology Inc., Ltd. | |
| Study of Neoantigen mRNA Vaccines in Patients With Resectable Pancreatic Cancer | NCT06326736 | Pancreatic Canc... | Surgery Camrelizumab SJ-Neo006 Gemcitabine+Abr... | 18 Years - 75 Years | Jinling Hospital, China | |
| A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors | NCT05389462 | Advanced Solid ... | ADCT-601 Gemcitabine | 18 Years - | ADC Therapeutics S.A. | |
| Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic Hyperbilirubinemia | NCT02267707 | Pancreatic Neop... Cholestasis | nab-paclitaxel Gemcitabine | 18 Years - | Celgene | |
| A Randomized Phase III Trial Comparing Folfirinox to Gemcitabine in Locally Advanced Pancreatic Carcinoma | NCT02539537 | Pancreatic Canc... Carcinoma | Gemcitabine Folinic Acid 5-Fluoro-uracil Oxaliplatin Irinotecan L-folinic | 18 Years - | UNICANCER | |
| A Study of the Treatment of Disitamab Vedotin in Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT06233864 | Pancreatic Canc... | Disitamab Vedot... Gemcitabine | 18 Years - | Sun Yat-sen University | |
| Intraoperative Radiation Therapy for Resectable Pancreatic Cancer | NCT05181488 | Resectable Panc... | intraoperative ... | 20 Years - | Gangnam Severance Hospital | |
| Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors | NCT03454035 | Tumor, Solid Pancreatic Canc... Melanoma | Ulixertinib Palbociclib | 18 Years - 99 Years | UNC Lineberger Comprehensive Cancer Center | |
| Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients | NCT06119217 | Pancreatic Canc... | TTX-030, nab-pa... TTX-030, budiga... Nab-Paclitaxel ... | 18 Years - | Trishula Therapeutics, Inc. | |
| Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | NCT01446952 | Pancreatic Canc... | Vitamin E δ-Toc... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer. | NCT05102110 | Non Small Cell ... Gastric Adenoca... Pancreatic Canc... Gall Bladder Ca... Bladder Cancer | Oricol Test | 18 Years - 99 Years | Origin Sciences | |
| Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors. | NCT05831995 | Advanced Solid ... RAS Mutation RAF Mutation NF1 Mutation | ABM-168 | 18 Years - | ABM Therapeutics Corporation | |
| Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer | NCT06389760 | Pancreatic Canc... | Nimotuzumab mFOLFIRINOX | 18 Years - 70 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer | NCT00630552 | Adenocarcinoma ... Metastatic Panc... Pancreatic Canc... | Placebo AMG 479 AMG 655 | 18 Years - | NantCell, Inc. | |
| MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial | NCT05975593 | Locally Advance... Locally Advance... Locally Advance... Locally Advance... Locally Advance... Cervical Cancer Pancreas Cancer Pancreatic Canc... Cancer of the C... Cancer of the P... | 18 Years - | Washington University School of Medicine | ||
| The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer | NCT05178628 | Pancreatic Canc... Thromboembolism | Innohep Chemotherapy: G... | 18 Years - | Institute of Molecular Medicine and Biomedical Research | |
| Preoperative Detection of Lymph Node Metastases in Pancreatic and Periampullary Carcinoma Using USPIO MRI | NCT04311047 | Pancreatic Canc... Periampullary C... | USPIO-enhanced ... | 18 Years - | Radboud University Medical Center | |
| Trial of Neoadjuvant Chemotherapy With S1 Plus Paclitaxel-albumin on Pancreatic Cancer | NCT03585062 | Pancreatic Canc... Neoadjuvant Che... | S1, Paclitaxel-albu... | 18 Years - 80 Years | Zhejiang Provincial People's Hospital | |
| Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | NCT02568267 | Breast Cancer Cholangiocarcin... Colorectal Canc... Head and Neck N... Lymphoma, Large... Melanoma Neuroendocrine ... Non-Small Cell ... Ovarian Cancer Pancreatic Canc... Papillary Thyro... Primary Brain T... Renal Cell Carc... Sarcomas Salivary Gland ... Adult Solid Tum... | Entrectinib | 18 Years - | Hoffmann-La Roche | |
| Intravenous Human Albumin In Improving Pancreaticoduodenectomy Outcomes | NCT04418739 | Pancreaticoduod... Pancreatic Fist... Delayed Gastric... Pancreatic Canc... Anastomotic Lea... | Human albumin | - | Universiti Kebangsaan Malaysia Medical Centre | |
| Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms | NCT01640522 | Hepatocellular ... Primary Liver C... Bile Duct Cance... Pancreatic Canc... Gallbladder Can... Colorectal Carc... Liver Metastase... | Collaborative C... Enhanced usual ... | 18 Years - | University of Pittsburgh | |
| Study of Stereotactic Body Radiation Therapy in Patients With Intact Pancreatic Cancer | NCT01342354 | Pancreatic Canc... | Stereotactic Ra... | 18 Years - | University of Chicago | |
| Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca | NCT03919292 | Solid Tumor, Ad... | Neratinib Divalproex Sodi... | 18 Years - | Virginia Commonwealth University | |
| Perception Prognosis, Goals of Treatment, and Communication | NCT01401894 | Gastric Cancer Esophageal Canc... Pancreatic Canc... Liver Cancer Biliary Cancer | 18 Years - | Massachusetts General Hospital | ||
| Florida Pancreas Collaborative Next Generation Biobank | NCT03851133 | Pancreatic Canc... Cancer Cachexia | Blood Sample Co... Tumor Sample co... Data Collection | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | NCT04969835 | Pancreatic Canc... Colorectal Canc... Non-small Cell ... Head and Neck C... Cancer of Unkno... Ovarian Cancer Breast Cancer Soft Tissue Sar... Bladder Cancer Oesophageal Can... Prostate Cancer Biliary Tract C... | AVA6000 | 18 Years - | Avacta Life Sciences Ltd | |
| Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer | NCT00268411 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - | National Cancer Institute (NCI) | |
| An Exploratory Trial to Evaluate Efficacy and Safety for Combination Treatment of Adenovirus Double Suicide Gene Therapy | NCT04739046 | Pancreas Cancer | Theragene arm | 19 Years - 75 Years | Seoul National University Bundang Hospital | |
| Enhancing Fitness Before Pancreatic Surgery | NCT02940067 | Pancreatic Canc... Pancreatitis, C... | MedEx | 18 Years - | Royal Surrey County Hospital NHS Foundation Trust |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
